B. Hermes et al., Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars, J INVES DER, 116(3), 2001, pp. 387-393
In order to explore possible mechanisms involved in the previously document
ed turnover of mast cell subpopulations in human cutaneous scars, we have e
xamined selected factors known to stimulate and/or modulate mast cell hyper
plasia (SCF, NGF, TGF beta1, GM-CSF) and their receptors in human cutaneous
scar tissue. On immunohistochemistry, numbers of SCF- and TGF beta1-positi
ve cells were significantly increased in the epidermis and throughout the d
ermis in scars (n = 27) of varying ages (4-369 d old), compared with normal
skin (n = 12). Furthermore, TR beta RI, II, and the NGF-p75 receptors were
significantly increased in the epidermis, TR beta RI and NGF-TrkA througho
ut the dermis, and TR beta RII, NGF-p75, and GM-CSFR only in the mid- and l
ower dermis of scars. NGF and GM-CSF expression was in contrast scarce and
weak, with no differences between normal skin and scars. In tissue extracts
, mRNA levels of SCF, TGF beta1, TR betaI and II, and both NGF-receptors, b
ut not GM-CSFR, were significantly increased as well. TR betaI and II were
identified in up to 90% and 83%, respectively, of isolated normal skin mast
cells on flow cytometry, and GM-CSFR and NGFR-p75 were identified on 70% a
nd 73%, respectively, of avidin-positive normal mast cells on double immuno
fluorescence microscopy. As described before for the SCF receptor KIT, GM-C
SFR and NGFR-p75 were partly or entirely downregulated on avidin-positive m
ast cells in scars. The marked upregulation of TGF beta1, its type I and II
receptors, and SCF suggest that these factors play a major role in the orc
hestration of mast cell increase in human cutaneous scars whereas the role
of NGF and GM-CSF is less clear, despite the significant upregulation of th
eir receptors.